Technical challenges in the isolation and analysis of circulating tumor cells

Emma E. van der Toom, James E. Verdone, Michael A. Gorin, Kenneth J. Pienta

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Increasing evidence suggests that cancer cells display dynamic molecular changes in response to systemic therapy. Circulating tumor cells (CTCs) in the peripheral blood represent a readily available source of cancer cells with which to measure this dynamic process. To date, a large number of strategies to isolate and characterize CTCs have been described. These techniques, however, each have unique limitations in their ability to sensitively and specifically detect these rare cells. In this review we focus on the technical limitations and pitfalls of the most common CTC isolation and detection strategies. Additionally, we emphasize the difficulties in correctly classifying rare cells as CTCs using common biomarkers. As for assays developed in the future, the first step must be a uniform and clear definition of the criteria for assigning an object as a CTC based on disease-specific biomarkers.

Original languageEnglish (US)
Pages (from-to)62754-62766
Number of pages13
Issue number38
StatePublished - 2016


  • CTCs
  • Rare cell isolation
  • circulating tumor cells
  • prostate cancer

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Technical challenges in the isolation and analysis of circulating tumor cells'. Together they form a unique fingerprint.

Cite this